THE CURRENT STATUS OF THE MECHANISM OF THE CALCIUM-CHANNEL ANTAGONISTS

被引：19
|
作者：
ALLEN, JC
机构：
来源：
PROGRESS IN CARDIOVASCULAR DISEASES | 1982年 / 25卷 / 02期
关键词：
D O I：
10.1016/0033-0620(82)90024-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 140
页数：8
相关论文
共 50 条
  • [41] PHARMACOLOGICAL BASIS FOR USE OF CALCIUM-CHANNEL ANTAGONISTS IN HYPERTENSION
    SCRIABINE, A
    KAZDA, S
    GARTHOFF, B
    NICKERSON, PA
    ANGIOLOGY, 1988, 39 (01) : 94 - 99
  • [42] SITES, MECHANISMS OF ACTION, AND DIFFERENTIATION OF CALCIUM-CHANNEL ANTAGONISTS
    TRIGGLE, DJ
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (07) : S422 - S429
  • [43] Conflict of interest in the debate over calcium-channel antagonists
    Opie, L
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23): : 1696 - 1697
  • [44] PHARMACOKINETIC INTERACTIONS WITH CALCIUM-CHANNEL ANTAGONISTS .1.
    SCHLANZ, KD
    MYRE, SA
    BOTTORFF, MB
    CLINICAL PHARMACOKINETICS, 1991, 21 (05) : 344 - 356
  • [45] CALCIUM-CHANNEL ANTAGONISTS DECREASE THE ETHANOL WITHDRAWAL SYNDROME
    LITTLE, HJ
    DOLIN, SJ
    HALSEY, MJ
    LIFE SCIENCES, 1986, 39 (22) : 2059 - 2065
  • [46] CENTRAL CARDIOVASCULAR ACTIONS OF CALCIUM-CHANNEL ANTAGONISTS IN DOGS
    DAMASEMICHEL, C
    MONTASTRUC, JL
    MONTASTRUC, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOL 3 SUPPL: CENTRAL EFFECTS OF CALCIUM ANTAGONISTS, 1989, : S57 - S64
  • [47] POTENTIATION OF DEPOLARIZING NEUROMUSCULAR BLOCKADE BY CALCIUM-CHANNEL ANTAGONISTS
    MCISAAC, R
    ALLEN, M
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1388 - 1388
  • [48] Conflict of interest in the debate over calcium-channel antagonists
    Stelfox, HT
    Chua, G
    O'Rourke, K
    Detsky, AS
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (02): : 101 - 106
  • [49] CENTRAL CARDIOVASCULAR ACTIONS OF CALCIUM-CHANNEL ANTAGONISTS IN DOGS
    DAMASEMICHEL, C
    MONTASTRUC, JL
    MONTASTRUC, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1989, 3 : S57 - S64
  • [50] Comment: mibefradil, a new class of calcium-channel antagonists
    Otterman, S
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (12) : 1372 - 1372
12345